Variability_NN at_IN Human_NP Immunodeficiency_NN Virus_NP Type_NP 1_CD Subtype_NP C_NP Protease_NP Cleavage_NP Sites_NP :_: an_DT Indication_NN of_IN Viral_NP Fitness_NP ?_SENT Naturally_RB occurring_VBG polymorphisms_NNS in_IN the_DT protease_NN of_IN human_JJ immunodeficiency_NN virus_NN type_NN 1_CD (_( HIV-1_NP )_) subtype_NN C_NP would_MD be_VB expected_VBN to_TO lead_VB to_TO adaptive_JJ (_( compensatory_JJ )_) changes_NNS in_IN protease_NN cleavage_NN sites_NNS ._SENT To_TO test_VB this_DT hypothesis_NN ,_, we_PP examined_VBD the_DT prevalences_NNS and_CC patterns_NNS of_IN cleavage_NN site_NN polymorphisms_NNS in_IN the_DT Gag_NP ,_, Gag-Pol_NP ,_, and_CC Nef_NP cleavage_NN sites_NNS of_IN C_NP compared_VBN to_TO those_DT in_IN non-C_NN subtypes_NNS ._SENT Codon-based_JJ maximum-likelihood_JJ methods_NNS were_VBD used_VBN to_TO assess_VB the_DT natural_JJ selection_NN and_CC evolutionary_JJ history_NN of_IN individual_JJ cleavage_NN sites_NNS ._SENT Seven_CD cleavage_NN sites_NNS (_( p17/p24_NP ,_, p24/p2_NN ,_, NC/p1_NP ,_, NC/TFP_NP ,_, PR/RT_NP ,_, RT/p66_NP ,_, and_CC p66/IN_NNS )_) were_VBD well_RB conserved_VBN over_IN time_NN and_CC in_IN all_DT HIV-1_JJ subtypes_NNS ._SENT One_CD site_NN (_( p1/p6gag_NN )_) exhibited_VBN moderate_JJ variation_NN ,_, and_CC four_CD sites_NNS (_( p2/NC_NP ,_, TFP/p6pol_NP ,_, p6pol/PR_NN ,_, and_CC Nef_NP )_) were_VBD highly_RB variable_JJ ,_, both_CC within_IN and_CC between_IN subtypes_NNS ._SENT Three_CD of_IN the_DT variable_JJ sites_NNS are_VBP known_VBN to_TO be_VB major_JJ determinants_NNS of_IN polyprotein_NN processing_NN and_CC virion_NN production_NN ._SENT P2/NC_NP controls_VBZ the_DT rate_NN and_CC order_NN of_IN cleavage_NN ,_, p6gag_NN is_VBZ an_DT important_JJ phosphoprotein_NN required_VBN for_IN virion_NN release_NN ,_, and_CC TFP/p6pol_NP ,_, a_DT novel_JJ cleavage_NN site_NN in_IN the_DT transframe_JJ domain_NN ,_, influences_VBZ the_DT specificity_NN of_IN Gag-Pol_NP processing_NN and_CC the_DT activation_NN of_IN protease_NN ._SENT Overall_RB ,_, 58.3_CD %_NN of_IN the_DT 12_CD HIV-1_JJ cleavage_NN sites_NNS were_VBD significantly_RB more_RBR diverse_JJ in_IN C_NP than_IN in_IN B_NP viruses_NNS ._SENT When_WRB analyzed_VBN as_IN a_DT single_JJ concatenated_VBN fragment_NN of_IN 360_CD bp_NN ,_, 96.0_CD %_NN of_IN group_NN M_NP cleavage_NN site_NN sequences_NNS fell_VBD into_IN subtype-specific_JJ phylogenetic_JJ clusters_NNS ,_, suggesting_VBG that_IN they_PP coevolved_VBD with_IN the_DT virus_NN ._SENT Natural_JJ variation_NN at_IN C_NP cleavage_NN sites_NNS may_MD play_VB an_DT important_JJ role_NN ,_, not_RB only_RB in_IN regulation_NN of_IN the_DT viral_JJ cycle_NN but_CC also_RB in_IN disease_NN progression_NN and_CC response_NN to_TO therapy_NN ._SENT One_CD of_IN the_DT most_RBS dramatic_JJ changes_NNS in_IN the_DT human_JJ immunodeficiency_NN virus_NN type_NN 1_CD (HIV-1)-AIDS_NNS epidemic_NN has_VBZ been_VBN the_DT rapid_JJ emergence_NN and_CC devastating_JJ spread_NN of_IN subtype_NN C_NP viruses_NNS ._SENT HIV-1_NP C_NP now_RB accounts_VBZ for_IN >56_JJ %_NN of_IN all_DT circulating_VBG viruses_NNS and_CC is_VBZ the_DT most_RBS commonly_RB transmitted_VBN subtype_NN worldwide_RB ._SENT Subtype_NN C_NP predominates_VBZ in_IN southern_JJ Africa_NP and_CC India_NP and_CC is_VBZ increasing_VBG in_IN frequency_NN in_IN China_NP and_CC Brazil_NP ._SENT The_DT disproportionate_JJ increase_NN in_IN C_NP viruses_NNS relative_JJ to_TO other_JJ HIV-1_NP strains_NNS suggests_VBZ that_IN subtype_NN C_NP may_MD be_VB more_RBR easily_RB transmitted_VBN or_CC that_IN it_PP has_VBZ a_DT higher_JJR level_NN of_IN "_`` fitness_NN "_'' at_IN the_DT population_NN level_NN ._SENT One_CD possible_JJ explanation_NN is_VBZ that_IN founder_NN effects_NNS relating_VBG to_TO the_DT ongoing_JJ introduction_NN of_IN subtype_NN C_NP into_IN new_JJ population_NN groups_NNS with_IN different_JJ host_NN factors_NNS ,_, or_CC different_JJ social_JJ and_CC sexual_JJ practices_NNS ,_, may_MD be_VB responsible_JJ for_IN the_DT rapid_JJ spread_NN ._SENT However_RB ,_, founder_NN and_CC host_NN effects_NNS cannot_MD account_VB for_IN the_DT fact_NN that_IN C_NP viruses_NNS are_VBP overtaking_VBG preexisting_VBG virus_NN subtypes_NNS in_IN several_JJ different_JJ geographical_JJ regions_NNS ,_, including_VBG Yunnan_NP Province_NP in_IN China_NP and_CC the_DT southern_JJ region_NN of_IN Brazil_NP ._SENT It_PP is_VBZ increasingly_RB evident_JJ that_IN additional_JJ (_( nonhost_JJ )_) viral_JJ factors_NNS are_VBP also_RB contributing_VBG to_TO the_DT rapid_JJ spread_NN of_IN HIV-1_NP C._NP Viral_NP studies_NNS indicate_VBP that_IN subtype_NN C_NP has_VBZ distinct_JJ genetic_JJ and_CC phenotypic_JJ properties_NNS that_WDT differentiate_VBP it_PP from_IN other_JJ HIV-1_JJ subtypes_NNS ._SENT Various_JJ studies_NNS have_VBP postulated_VBN that_IN an_DT extra_JJ NF-kappaB_NP binding_JJ site_NN in_IN the_DT long_JJ terminal_NN repeat_NN ,_, a_DT prematurely_RB truncated_VBN Rev_NP protein_NN ,_, or_CC a_DT 5-amino-acid_JJ insertion_NN in_IN Vpu_NP may_MD influence_VB viral_JJ gene_NN expression_NN ,_, altering_VBG the_DT transmissibility_NN and_CC pathogenesis_NN of_IN C_NP viruses_NNS ._SENT Factors_NNS related_VBN to_TO viral_JJ entry_NN and_CC pathogenesis_NN ,_, such_JJ as_IN the_DT CCR5_NP and_CC non-syncytium-inducing_JJ properties_NNS of_IN C_NP isolates_VBZ ,_, may_MD also_RB contribute_VB to_TO the_DT increased_VBN spread_NN of_IN C_NP viruses_NNS ._SENT One_CD area_NN of_IN research_NN that_WDT is_VBZ receiving_VBG consideration_NN is_VBZ the_DT possibility_NN that_IN C_NP viruses_NNS have_VBP a_DT more_RBR active_JJ ,_, catalytically_RB efficient_JJ protease_NN ._SENT The_DT C_NP protease_NN is_VBZ highly_RB conserved_VBN at_IN the_DT amino_NN acid_NN level_NN and_CC has_VBZ a_DT distinct_JJ signature_NN sequence_NN that_WDT differentiates_VBZ it_PP from_IN those_DT of_IN subtypes_NNS A_NP ,_, B_NP ,_, and_CC D_NP ._SENT A_DT subset_NN of_IN these_DT signature_NN residues_NNS ,_, present_JJ in_IN the_DT hinge_NN (_( M36I/R41K/H69K_NP )_) and_CC alpha-helix_NP (_( I89M_NP )_) of_IN C_NP (_( and_CC A_NP )_) proteases_NNS ,_, has_VBZ been_VBN linked_VBN to_TO increased_VBN catalytic_JJ activity_NN ._SENT Another_DT signature_NN pattern_NN ,_, identified_VBN in_IN >80_JJ %_NN of_IN C_NP viruses_NNS from_IN South_NP Africa_NP ,_, is_VBZ T12S/T15V/L19I/I93L_NP ._SENT The_DT 12S_NP ,_, 15V_NP ,_, and_CC 19I_NP residues_NNS of_IN this_DT motif_NN are_VBP located_VBN near_IN the_DT N_NP terminus_NN of_IN the_DT protease_NN in_IN an_DT extended_JJ beta-chain_NN ._SENT The_DT 93L_NN polymorphism_NN is_VBZ located_VBN within_IN a_DT hydrogen-bonded_JJ turn_NN immediately_RB upstream_RB from_IN the_DT protease-reverse_JJ transcriptase_NN (_( RT_NP )_) cleavage_NN site_NN ,_, in_IN close_JJ proximity_NN to_TO 12S/15V/19I_NP and_CC the_DT dimerization_NN domain_NN ._SENT All_DT of_IN these_DT polymorphisms_NNS lie_VBP outside_IN the_DT catalytic_JJ site_NN of_IN the_DT protease_NN ,_, in_IN regions_NNS that_WDT would_MD be_VB expected_VBN to_TO alter_VB the_DT enzyme_NN 's_POS activity_NN toward_IN its_PP$ natural_JJ cleavage_NN sites_NNS ,_, leading_VBG to_TO adaptive_JJ (_( compensatory_JJ )_) changes_NNS in_IN the_DT cleavage_NN site_NN itself_PP ._SENT Since_IN protease_NN inhibitors_NNS (_( PIs_NP )_) are_VBP currently_RB the_DT most_RBS active_JJ antiretroviral_JJ drugs_NNS used_VBN for_IN the_DT treatment_NN of_IN HIV-1_NP ,_, it_PP is_VBZ important_JJ to_TO collect_VB information_NN ,_, not_RB only_RB on_IN the_DT C_NP protease_NN but_CC also_RB on_IN its_PP$ drug_NN responsiveness_NN ,_, substrate-inhibitor_NN specificities_NNS ,_, and_CC cleavage_NN site_NN characteristics_NNS ._SENT This_DT information_NN is_VBZ needed_VBN to_TO design_VB PIs_NNS that_WDT are_VBP maximally_RB effective_JJ against_IN C_NP viruses_NNS and_CC to_TO obtain_VB new_JJ insights_NNS into_IN the_DT mechanism_NN of_IN drug_NN resistance_NN ._SENT Studies_NNS have_VBP shown_VBN that_IN resistance_NN mutations_NNS in_IN the_DT B_NP protease_NN are_VBP associated_VBN with_IN impaired_JJ proteolytic_JJ processing_NN ,_, decreased_VBD enzymatic_JJ activity_NN ,_, and_CC a_DT failure_NN to_TO produce_VB mature_JJ infectious_JJ virions_NNS ._SENT Compensatory_JJ cleavage_NN site_NN mutations_NNS can_MD partially_RB compensate_VB for_IN these_DT defects_NNS ._SENT In_IN this_DT report_NN ,_, we_PP describe_VBP the_DT natural_JJ variability_NN of_IN subtype_NN C_NP cleavage_NN sites_NNS in_IN viruses_NNS from_IN Africa_NP ,_, India_NP ,_, and_CC Brazil_NP and_CC compare_VB the_DT results_NNS to_TO cleavage_NN site_NN patterns_NNS in_IN representative_JJ B_NN and_CC group_NN M_NN viruses_NNS ._SENT Cleavage_NN site_NN characteristics_NNS ._SENT |_SYM The_DT HIV-1_JJ protease_NN is_VBZ a_DT small_JJ ,_, 99-amino-acid_JJ aspartic_JJ enzyme_NN that_WDT mediates_VBZ the_DT cleavage_NN of_IN Gag_NP ,_, Gag-Pol_NP ,_, and_CC Nef_NP precursor_NN polyproteins_NNS ._SENT These_DT reactions_NNS occur_VBP late_RB in_IN the_DT viral_JJ life_NN cycle_NN ,_, during_IN virion_NN assembly_NN and_CC maturation_NN at_IN the_DT cell_NN surface_NN ._SENT The_DT process_NN is_VBZ highly_RB specific_JJ ,_, temporally_RB regulated_VBN ,_, and_CC essential_JJ for_IN the_DT production_NN of_IN infectious_JJ viral_JJ particles_NNS (_( -_: ,_, )_) ._SENT As_IN shown_VBN in_IN Fig._NN ,_, the_DT main_JJ structural_JJ proteins_NNS are_VBP formed_VBN by_IN cleavage_NN of_IN the_DT Pr55gag_NP polyprotein_NN into_IN matrix_NN (_( MA_NP ;_: p17_JJ )_) ,_, capsid_NN (_( CA_NP ;_: p24_NP )_) ,_, nucleocapsid_NP (_( NC_NP ;_: p7_JJ )_) ,_, p6gag_NN ,_, and_CC two_CD spacer_NN peptides_NNS ,_, p2_JJ and_CC p1_JJ ._SENT The_DT viral_JJ enzymes_NNS are_VBP formed_VBN by_IN cleavage_NN of_IN Pr160gag-pol_NP ,_, a_DT fusion_NN protein_NN derived_VBN by_IN ribosomal_JJ frame_NN shifting_VBG ._SENT Although_IN Pr160gag-pol_NP also_RB contains_VBZ p17_JJ ,_, p24_JJ ,_, and_CC p2_NN ,_, its_PP$ C-terminal_JJ cleavage_NN products_NNS are_VBP NC_NP ,_, a_DT transframe_NN protein_NN (_( TFP_NN )_) ,_, p6pol_NP ,_, protease_NN (_( PR_NP )_) ,_, reverse_JJ transcriptase_NN (_( RTp51_NP )_) ,_, RNase_NP H_NP (_( RTp66_NP )_) ,_, and_CC integrase_NN (_( IN_IN )_) ._SENT In_IN total_NN ,_, 12_CD proteolytic_JJ reactions_NNS are_VBP required_VBN to_TO generate_VB a_DT mature_JJ infectious_JJ virion_NN ._SENT Each_DT reaction_NN occurs_VBZ at_IN a_DT unique_JJ cleavage_NN site_NN that_WDT differs_VBZ in_IN amino_NN acid_NN composition_NN ._SENT Some_DT cleavage_NN sites_NNS contain_VBP phosphorylated_JJ Ser/Thr_NP or_CC Tyr_NP residues_NNS that_WDT alter_VBP the_DT sites_NNS '_POS susceptibilities_NNS to_TO cleavage_NN ._SENT P6gag_NP ,_, the_DT major_JJ phosphoprotein_NN of_IN HIV-1_NP ,_, plays_VBZ an_DT essential_JJ role_NN in_IN the_DT release_NN of_IN virus_NN from_IN the_DT membranes_NNS of_IN infected_JJ cells_NNS ._SENT Sequence_NN data_NNS and_CC construction_NN of_IN cleavage_NN site_NN fragments_NNS ._SENT |_SYM A_DT total_NN of_IN 84_CD full-length_JJ nucleotide_NN sequences_NNS were_VBD selected_VBN for_IN analysis_NN ._SENT These_DT sequences_NNS included_VBD two_CD C_NP isolates_NNS from_IN South_NP Africa_NP ,_, TV001_NP and_CC TV002_NP ,_, in_IN addition_NN to_TO another_DT 25_CD subtype_NN C_NP ,_, 30_CD subtype_NN B_NN ,_, and_CC 27_CD representative_NN group_NN M_NP reference_NN sequences_NNS (_( including_VBG A_NP [_SYM n_NN =_SYM 3_CD ]_SYM ,_, B_NP [_SYM n_NN =_SYM 4_CD ]_SYM ,_, C_NP [_SYM n_NN =_SYM 5_CD ]_SYM ,_, D_NP [_SYM n_NN =_SYM 3_CD ]_SYM ,_, F1_NP and_CC F2_NP [_SYM n_NN =_SYM 4_CD ]_SYM ,_, G_NP [_SYM n_NN =_SYM 2_CD ]_SYM ,_, H_NP [_SYM n_NN =_SYM 2_CD ]_SYM ,_, J_NP [_SYM n_NN =_SYM 2_CD ]_SYM ,_, and_CC K_NP [_SYM n_NN =_SYM 2_CD ]_SYM subtypes_NNS )_) extracted_VBN from_IN the_DT Los_NP Alamos_NP database_NN ._SENT Sequences_NNS were_VBD selected_VBN based_VBN on_IN the_DT patient_NN being_VBG treatment_NN naive_NN ._SENT Since_IN the_DT prevalence_NN of_IN drug_NN resistance_NN in_IN untreated_JJ patients_NNS has_VBZ been_VBN reported_VBN to_TO range_VB from_IN 1_CD to_TO 11_CD %_NN ,_, sequences_NNS were_VBD also_RB screened_VBN and_CC excluded_VBN from_IN the_DT study_NN if_IN they_PP were_VBD found_VBN to_TO contain_VB primary_JJ resistance_NN mutations_NNS ._SENT The_DT majority_NN of_IN the_DT sequences_NNS were_VBD obtained_VBN by_IN direct_JJ DNA_NP PCR_NP amplification_NN and_CC cloning_VBG of_IN peripheral_JJ blood_NN mononuclear_JJ cells_NNS ._SENT Nucleotide_NN sequences_NNS were_VBD aligned_VBN by_IN CLUSTAL_NP W_NP and_CC manually_RB edited_VBN with_IN the_DT codon_NN alignment_NN of_IN the_DT Genetic_NP Data_NP Environment_NP (_( GDE_NP version_NN 2.2_CD )_) program_NN ._SENT Calculation_NN of_IN the_DT pairwise_JJ distance_NN matrix_NN ,_, phylogenetic_JJ inference_NN ,_, and_CC tree_NN construction_NN were_VBD performed_VBN on_IN a_DT dual-processor_NN Linux_NP computer_NN by_IN using_VBG the_DT PAUP_JJ version_NN 4.0b2a_JJ program_NN (_( Sinauer_NP Associates_NPS ,_, Sunderland_NP ,_, Mass._NP )_) and_CC a_DT GDE_NP for_IN Linux_NP HIV-1_NP interface_NN ._SENT Thirty-base-pair_NN segments_NNS ,_, consisting_VBG of_IN 15_CD nucleotides_NNS (_( 5_CD amino_NN acids_NNS )_) on_IN each_DT side_NN of_IN the_DT 12_CD cleavage_NN sites_NNS ,_, were_VBD extracted_VBN and_CC concatenated_VBN into_IN a_DT 360-bp_JJ nucleotide_NN sequence_NN ._SENT Reconstruction_NN of_IN ancestral_JJ cleavage_NN site_NN sequences_NNS ._SENT |_SYM To_TO examine_VB the_DT evolutionary_JJ histories_NNS of_IN individual_JJ cleavage_NN sites_NNS ,_, Phylogenetic_NP Analysis_NP under_IN Maximum_NP Likelihood_NP (_( PAML_NP )_) software_NN was_VBD used_VBN to_TO identify_VB amino_NN acid_NN and_CC nucleotide_NN substitutions_NNS along_IN each_DT branch_NN of_IN the_DT tree_NN ._SENT Branch_NN lengths_NNS were_VBD estimated_VBN using_VBG a_DT nucleotide_NN substitution_NN model_NN ;_: amino_NN acid_NN sequences_NNS were_VBD deduced_VBN from_IN the_DT reconstructed_JJ nucleotide_NN triplets_NNS ._SENT The_DT analyses_NNS involved_VBD the_DT use_NN of_IN maximum-likelihood_JJ methods_NNS and_CC a_DT time-reversible_JJ model_NN which_WDT assume_VBP different_JJ substitution_NN rates_NNS ,_, base_NN frequencies_NNS ,_, and_CC transition/transversion_NN rate_NN ratios_NNS (_( kappa_NN )_) ._SENT Using_VBG this_DT approach_NN ,_, we_PP were_VBD able_JJ to_TO reconstruct_VB the_DT ancestral_JJ sequences_NNS and_CC internal_JJ nodes_NNS for_IN each_DT of_IN the_DT 12_CD protease_NN cleavage_NN sites_NNS in_IN the_DT B_NP ,_, C_NP ,_, and_CC M_NP group_NN data_NN sets_NNS ._SENT The_DT number_NN of_IN proximal_JJ ancestors_NNS for_IN each_DT data_NNS set_VBN was_VBD n_NN -_: 1_LS ,_, which_WDT translated_VBN into_IN 29_CD ancestral_JJ sequences_NNS for_IN subtype_NN B_NP ,_, 26_CD sequences_NNS for_IN subtype_NN C_NP ,_, and_CC 26_CD sequences_NNS for_IN the_DT group_NN M_NN viruses_NNS ._SENT The_DT most_RBS recent_JJ common_JJ ancestor_NN (_( MRCA_NP )_) nucleotide_NN sequence_NN for_IN each_DT virus_NN in_IN the_DT three_CD data_NN sets_NNS was_VBD saved_VBN and_CC translated_VBN into_IN its_PP$ corresponding_JJ amino_NN acids_NNS ._SENT Diversity_NN and_CC cleavage_NN site_NN polymorphisms_NNS ._SENT |_SYM Nucleotide_NN diversity_NN at_IN cleavage_NN sites_NNS was_VBD measured_VBN using_VBG a_DT Kimura_NP 2-alpha_NP parameter_NN model_NN with_IN a_DT distance_NN matrix_NN implemented_VBN in_IN the_DT MEGA_NP program_NN version_NN 2.0_CD (_( Arizona_NP State_NP University_NP ,_, Tempe_NP )_) ._SENT Amino_NN acid_NN diversity_NN was_VBD measured_VBN using_VBG a_DT Poisson_NP distribution_NN method_NN implemented_VBN in_IN the_DT same_JJ MEGA_NP package_NN ._SENT P_NN values_NNS for_IN diversity_NN measurements_NNS were_VBD calculated_VBN by_IN applying_VBG the_DT t_NN test_NN to_TO the_DT distance_NN matrix_NN of_IN each_DT data_NNS set_VBD ._SENT To_TO determine_VB whether_IN the_DT sequences_NNS had_VBD evolved_VBN over_IN time_NN ,_, amino_NN acid_NN profiles_NNS for_IN individual_JJ Gag_NP ,_, Gag-Pol_NP ,_, and_CC Nef_NP cleavage_NN sites_NNS were_VBD compared_VBN to_TO the_DT inferred_VBN MRCA_NP for_IN that_DT site_NN ._SENT Assessment_NN of_IN positive_JJ selection_NN pressure_NN ._SENT |_SYM Nucleotide_NN sequences_NNS were_VBD also_RB analyzed_VBN with_IN Codeml_NP ,_, a_DT program_NN from_IN the_DT PAML_NP software_NN package_NN ._SENT The_DT likelihood_NN ratio_NN test_NN and_CC recently_RB developed_VBN codon-based_JJ models_NNS were_VBD used_VBN to_TO assess_VB natural_JJ selection_NN and_CC adaptive_JJ evolution_NN at_IN the_DT amino_NN acid_NN level_NN ._SENT These_DT selection_NN models_NNS use_VBP maximum-likelihood_JJ scores_NNS to_TO account_VB for_IN variation_NN in_IN the_DT dn/ds_NNS (_( nonsynonymous/synonymous_JJ )_) ratio_NN (_( omega_NN )_) at_IN individual_JJ codons_NNS along_IN the_DT length_NN of_IN the_DT sequence_NN ._SENT High_JJ rates_NNS of_IN synonymous_JJ mutation_NN are_VBP indicative_JJ of_IN conservation_NN and_CC a_DT strict_JJ requirement_NN for_IN biological_JJ function_NN ,_, while_IN high_JJ rates_NNS of_IN nonsynonymous_JJ substitution_NN are_VBP indicative_JJ of_IN adaptive_JJ change_NN in_IN response_NN to_TO host_VB selection_NN pressure_NN ._SENT An_DT individual_JJ amino_NN acid_NN was_VBD considered_VBN to_TO be_VB positively_RB selected_VBN if_IN the_DT dn/ds_NNS ratio_NN was_VBD significantly_RB greater_JJR than_IN 1.0_CD ._SENT Viral_JJ characteristics_NNS ._SENT |_SYM No_DT primary_JJ RT-_NN or_CC PI-resistant_JJ mutations_NNS were_VBD detected_VBN among_IN the_DT 84_CD full-length_JJ sequences_NNS selected_VBN for_IN study_NN ._SENT Although_IN attempts_NNS were_VBD made_VBN to_TO include_VB only_JJ sequences_NNS amplified_VBN directly_RB from_IN HIV-1_JJ proviral_JJ DNA_NN and_CC to_TO match_VB these_DT sequences_NNS based_VBN on_IN duration_NN of_IN infection_NN ,_, plasma_NN viral_JJ load_NN ,_, and_CC CD4_NP count_NN ,_, this_DT proved_VBN difficult_JJ ._SENT A_DT surprisingly_RB small_JJ amount_NN of_IN full-length_JJ sequence_NN data_NNS was_VBD available_JJ from_IN treatment-naive_JJ patients_NNS infected_VBN with_IN subtype_NN B_NN ,_, and_CC when_WRB available_JJ ,_, it_PP was_VBD often_RB poorly_RB annotated_VBN ._SENT Despite_IN these_DT limitations_NNS ,_, the_DT frequency_NN and_CC pattern_NN of_IN naturally_RB occurring_VBG polymorphisms_NNS observed_VBN in_IN this_DT study_NN were_VBD remarkably_RB similar_JJ to_TO those_DT reported_VBN for_IN a_DT control_NN group_NN of_IN subtype_NN B_NN infections_NNS treated_VBN with_IN nucleoside_NN reverse_JJ transcriptase_NN inhibitors_NNS but_CC not_RB with_IN PIs_NP or_CC nonnucleoside_JJ reverse_JJ transcriptase_NN inhibitors_NNS ._SENT Most_JJS of_IN the_DT non-C_NN sequences_NNS came_VBD from_IN regions_NNS of_IN the_DT world_NN where_WRB treatment_NN is_VBZ not_RB yet_RB readily_RB available_JJ ._SENT Genetic_JJ diversity_NN and_CC patterns_NNS of_IN amino_NN acid_NN variability_NN at_IN individual_JJ cleavage_NN sites_NNS ._SENT |_SYM Variation_NN at_IN the_DT 12_CD cleavage_NN sites_NNS of_IN subtypes_NNS B_NP and_CC C_NP and_CC group_NN M_NN is_VBZ shown_VBN in_IN Table_NP ._SENT Seven_CD (_( 58.3_CD %_NN )_) sites_NNS (_( p17/p24_NP ,_, p24/p2_NN ,_, NC/p1_NP ,_, NC/TFP_NP ,_, PR/RT_NP ,_, RT/p66_NP ,_, and_CC p66/IN_NNS )_) were_VBD found_VBN to_TO be_VB relatively_RB well_RB conserved_VBN ,_, both_CC over_IN time_NN and_CC between_IN subtypes_NNS ,_, with_IN a_DT mean_JJ intrasubtype_NN distance_NN ranging_VBG from_IN 0.40_CD +-_NN 0.20_CD %_NN to_TO 7.49_CD +-_NN 5.62_CD %_NN ._SENT The_DT remaining_VBG five_CD (_( 41.7_CD %_NN )_) sites_NNS exhibited_VBD moderate_JJ (_( p1/p6gag_NN )_) to_TO extensive_JJ (_( p2/NC_NP ,_, TFP/p6pol_NP ,_, p6pol/PR_NN ,_, and_CC Nef_NP )_) variation_NN ,_, with_IN mean_JJ intrasubtype_NN diversities_NNS reaching_VBG levels_NNS as_IN high_JJ as_IN 42.42_CD +-_NN 15.16_CD %_NN ._SENT For_IN the_DT purposes_NNS of_IN this_DT study_NN ,_, we_PP have_VBP referred_VBN to_TO these_DT three_CD patterns_NNS as_IN conserved_VBN ,_, moderately_RB variable_JJ ,_, and_CC variable_JJ ._SENT Polymorphisms_NNS were_VBD more_RBR common_JJ among_IN C_NP than_IN B_NP viruses_NNS (_( P_NN <_SYM 0.0001_CD )_) ._SENT Overall_RB ,_, six_CD cleavage_NN sites_NNS (_( p17/p24_NP ,_, p2/NC_NP ,_, NC/p1_NP ,_, PR/RT_NP ,_, RT/p66_NP ,_, and_CC Nef_NP )_) had_VBD signficantly_RB higher_JJR levels_NNS of_IN diversity_NN among_IN C_NP viruses_NNS (_( P_NN <_SYM 0.0001_CD )_) ;_: five_CD sites_NNS (_( p24/p2_NP ,_, p1/p6gag_NP ,_, NC/TFP_NP ,_, p6pol/PR_NN ,_, and_CC p66/IN_NP )_) had_VBD similar_JJ levels_NNS of_IN diversity_NN in_IN both_DT subtypes_NNS ,_, and_CC one_CD site_NN ,_, TFP/p6pol_NP ,_, was_VBD highly_RB variable_JJ among_IN B_NN and_CC group_NN M_NN viruses_NNS (_( mean_JJ distances_NNS ,_, 16.7_CD and_CC 24.7_CD %_NN ,_, respectively_RB )_) but_CC relatively_RB conserved_VBN in_IN C_NP viruses_NNS (_( mean_JJ distance_NN ,_, 7.6_CD %_NN )_) (_( P_NN <_SYM 0.0001_CD )_) ._SENT Compared_VBN to_TO the_DT M_NP data_NNS set_VBD ,_, the_DT level_NN of_IN polymorphism_NN at_IN C_NP cleavage_NN sites_NNS was_VBD as_RB wide_JJ ranging_VBG as_IN that_WDT observed_VBD for_IN the_DT entire_JJ M_NP group_NN ,_, a_DT data_NNS set_VBD containing_VBG nine_CD different_JJ HIV-1_JJ subtypes_NNS ._SENT One_CD cleavage_NN site_NN ,_, p17/p24_NN ,_, was_VBD significantly_RB more_RBR diverse_JJ in_IN subtype_NN C_NP (_( mean_JJ divergence_NN ,_, 5.15_CD %_NN )_) than_IN in_IN group_NN M_NP (_( mean_JJ divergence_NN ,_, 2.23_CD %_NN )_) and_CC subtype_NN B_NN (_( mean_JJ divergence_NN ,_, 2.31_CD %_NN )_) viruses_NNS (_( <0.0001_JJ for_IN both_DT comparisons_NNS )_) ._SENT Seven_CD sites_NNS (_( p24/p2_NP ,_, p2/NC_NP ,_, NC/p1_NP ,_, p6pol/PR_NP ,_, RT/p66_NP ,_, p66/IN_NN ,_, and_CC Nef_NP )_) exhibited_VBD similar_JJ levels_NNS of_IN diversity_NN in_IN both_DT data_NN sets_VBZ (_( P_NN =_SYM 0.004_CD to_TO 0.961_CD )_) ._SENT Only_RB four_CD group_NN M_NN cleavage_NN sites_NNS (_( p1/p6gag_NP ,_, NC/TFP_NP ,_, TFP/p6pol_NP ,_, and_CC PR/RT_NP )_) had_VBD mean_JJ diversities_NNS that_WDT were_VBD significantly_RB greater_JJR than_IN that_DT observed_VBN for_IN subtype_NN C_NP (_( P_NN <_0.0001). 50_CD %_NN of_IN the_DT sites_NNS ,_, the_DT variability_NN of_IN B_NP viruses_NNS was_VBD significantly_RB lower_JJR than_IN that_DT observed_VBN for_IN subtype_NN C_NN or_CC group_NN M_NP (_( P_NN <_SYM 0.0001_CD )_) ,_, despite_IN the_DT fact_NN that_IN the_DT B_NP viruses_NNS covered_VBD a_DT broader_JJR time_NN frame_NN ._SENT The_DT observed_JJ polymorhpisms_NNS were_VBD not_RB randomly_RB distributed_VBN across_IN the_DT variable_JJ cleavage_NN sites_NNS but_CC were_VBD confined_VBN to_TO specific_JJ amino_NN acids_NNS ,_, most_JJS of_IN which_WDT were_VBD positively_RB selected_VBN in_IN C_NP but_CC not_RB in_IN B_NP viruses_NNS ._SENT The_DT least_JJS variable_JJ residues_NNS were_VBD the_DT P1_JJ positions_NNS of_IN p1/p6gag_NN ,_, TFP/p6pol_NP ,_, and_CC Nef_NP and_CC the_DT P1_NP '_POS positions_NNS of_IN p6pol/PR_NP and_CC Nef_NP ._SENT As_IN shown_VBN ,_, these_DT positions_NNS flank_VBP the_DT scissile_JJ bond_NN ,_, with_IN P1_NP located_VBN immediately_RB upstream_RB and_CC P1_NP '_POS located_VBN immediately_RB downstream_JJ of_IN the_DT cleavage_NN junction_NN ._SENT The_DT most_RBS variable_JJ positions_NNS were_VBD the_DT P1_NP ,_, P3_NP ,_, P4_NP ,_, P5_NP ,_, P3_NP '_POS ,_, and_CC P5_NP '_POS residues_NNS of_IN p2/NC_NN ;_: the_DT p3_NN '_POS residue_NN of_IN p1/p6gag_NN ;_: the_DT P1_NP '_POS and_CC P4_NP '_POS residues_NNS of_IN TFP/p6pol_NP ;_: the_DT P1_NP to_TO P4_NP residues_NNS of_IN p6pol/PR_NN ;_: and_CC the_DT P3_NP to_TO P5_NP and_CC P2_NP '_POS residues_NNS of_IN Nef_NP ._SENT Subtyping_NN and_CC phylogenetic-tree_NN analysis_NN ._SENT |_SYM When_WRB subjected_VBN to_TO phylogenetic_JJ analysis_NN ,_, the_DT concatenated_VBN 360-bp_JJ fragments_NNS of_IN the_DT group_NN M_NN data_NNS set_VBN fell_VBD into_IN eight_CD subtype-specific_JJ clusters_NNS representing_VBG subtypes_NNS A_NP ,_, B_NP and_CC D_NP ,_, C_NP ,_, F_NP ,_, G_NP ,_, H_NP ,_, J_NP ,_, and_CC K_NP ,_, with_IN the_DT cleavage_NN sequences_NNS for_IN subtypes_NNS B_NP and_CC D_NP segregating_VBG together_RB in_IN the_DT same_JJ subcluster_NN ._SENT This_DT pattern_NN was_VBD supported_VBN by_IN high_JJ bootstrap_NN values_NNS ,_, by_IN high-score_JJ maximum-likelihood_JJ trees_NNS ,_, and_CC by_IN phylogenetic_JJ analysis_NN of_IN the_DT deduced_VBN amino_NN acids_NNS ._SENT These_DT findings_NNS reveal_VBP the_DT subtype-specific_JJ nature_NN of_IN protease_NN cleavage_NN sites_NNS and_CC suggest_VBP that_IN the_DT evolution_NN of_IN cleavage_NN sites_NNS parallels_VBZ that_IN of_IN the_DT full-length_JJ genome_NN ._SENT With_IN the_DT exception_NN of_IN C.98IN022_NP ,_, B.AR00.ARMS008_NP ,_, and_CC B.US.P896_NP ,_, all_DT of_IN the_DT cleavage_NN site_NN fragments_NNS in_IN the_DT B_NP and_CC C_NP data_NNS sets_NNS segregated_VBD into_IN two_CD distinct_JJ monophyletic_JJ groups_NNS representing_VBG either_DT subtype_NN B_NN or_CC subtype_NN C_NN viruses_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT longer_JJR branch_NN lengths_NNS in_IN the_DT C_NP subcluster_NN were_VBD reflective_JJ of_IN the_DT increased_VBN diversity_NN of_IN C_NP viruses_NNS relative_JJ to_TO subtype_NN B._NP Identification_NP and_CC dating_VBG of_IN common_JJ ancestors_NNS ._SENT |_SYM Maximum-likelihood_NP methods_NNS were_VBD next_RB used_VBN to_TO reconstruct_VB the_DT internal_JJ nodes_NNS of_IN the_DT phylogenetic_JJ tree_NN and_CC to_TO estimate_VB the_DT times_NNS of_IN divergence_NN of_IN individual_JJ sequences_NNS from_IN their_PP$ MRCA_NP ._SENT These_DT estimates_NNS were_VBD determined_VBN by_IN measuring_VBG the_DT number_NN of_IN substitutions_NNS along_IN each_DT branch_NN of_IN the_DT tree_NN ._SENT MRCAs_NNS for_IN the_DT B_NP ,_, C_NP ,_, and_CC group_NN M_NN data_NN sets_NNS are_VBP shown_VBN in_IN Fig._NN ._SENT Two_CD different_JJ patterns_NNS were_VBD observed_VBN based_VBN on_IN the_DT relationship_NN between_IN a_DT given_VBN sequence_NN and_CC its_PP$ MRCA_NP ._SENT Conserved_VBN (_( n_NN =_SYM 7_CD )_) and_CC moderately_RB variable_JJ (_( n_NN =_SYM 1_CD )_) cleavage_NN sites_NNS shared_VBD the_DT same_JJ (_( identical_JJ )_) MRCA_NP among_IN all_DT three_CD data_NN sets_NNS ._SENT The_DT proximal_JJ location_NN of_IN the_DT MRCA_NP relative_NN to_TO the_DT root_NN of_IN the_DT tree_NN suggests_VBZ that_IN ,_, for_IN these_DT sequences_NNS ,_, cleavage_NN site_NN diversification_NN occurred_VBD after_IN subtype_NN divergence_NN ._SENT In_IN contrast_NN ,_, variable_JJ cleavage_NN sites_NNS (_( n_NN =_SYM 4_LS )_) showed_VBD a_DT high_JJ degree_NN of_IN divergence_NN both_CC from_IN their_PP$ subtype-specific_JJ MRCA_NP and_CC from_IN the_DT group_NN M_NP MRCA_NP ._SENT Ancestral_JJ nodes_NNS for_IN the_DT variable_JJ sites_NNS were_VBD located_VBN closer_RBR to_TO the_DT tips_NNS of_IN the_DT tree_NN (_( data_NNS available_JJ upon_IN request_NN )_) ._SENT Variability_NN of_IN cleavage_NN sites_NNS relative_JJ to_TO other_JJ regions_NNS of_IN the_DT HIV-1_JJ genome_NN ._SENT |_SYM For_IN C_NP viruses_NNS ,_, the_DT average_JJ intersequence_NN divergence_NN among_IN the_DT concatenated_VBN cleavage_NN site_NN fragments_NNS was_VBD higher_JJR (_( 10.1_CD %_NN )_) than_IN those_DT observed_VBN for_IN the_DT Gag_NP (_( 9.8_CD %_NN )_) and_CC Pol_NP (_( 5.8_CD %_NN )_) proteins_NNS but_CC lower_VB (_( 16.5_CD %_NN )_) than_IN that_WDT observed_VBD for_IN Nef_NP ._SENT In_IN contrast_NN ,_, B_NP cleavage_NN sites_NNS were_VBD significantly_RB less_JJR diverse_JJ (_( 4.8_CD %_NN ;_: P_NN <_0.0001) 97.0_CD %_NN of_IN P1-P1_NP '_POS amino_NN acids_NNS in_IN group_NN M_NN were_VBD nonpolar_JJ ._SENT Of_IN these_DT ,_, 77.8_CD %_NN were_VBD hydrophobic_JJ ,_, 21.5_CD %_NN were_VBD small_JJ amino_NN acids_NNS (_( 78.9_CD %_NN proline_NN ,_, 20.8_CD %_NN alanine_NN ,_, and_CC 0.3_CD %_NN glycine_NN )_) ,_, 0.3_CD %_NN were_VBD polar_JJ uncharged_JJ (_( one_CD serine_NN and_CC three_CD glutamine_NN )_) ,_, 0.2_CD %_NN were_VBD polar_JJ charged_JJ (_( one_CD arginine_NN and_CC one_CD aspartic_JJ acid_NN )_) ,_, and_CC 0.3_CD %_NN were_VBD ungrouped_JJ (_( cysteine_NN )_) residues_NNS ._SENT These_DT amino_NN acids_NNS were_VBD localized_VBN at_IN specific_JJ positions_NNS within_IN the_DT cleavage_NN sequence_NN ._SENT The_DT small_JJ amino_NN acids_NNS were_VBD localized_VBN primarily_RB to_TO the_DT P1_NP '_POS position_NN of_IN p17/p24_NN ,_, p24/p2_NN ,_, TFP/p6pol_NP ,_, p6pol/PR_NN ,_, and_CC PR/RT_NP ._SENT Hydrophobic_JJ amino_NN acids_NNS were_VBD concentrated_VBN at_IN the_DT P1-P1_NP '_POS junction_NN ._SENT As_IN previously_RB reported_VBN for_IN HIV-1_NP B_NP ,_, the_DT P1-P1_NP '_POS amino_NN acids_NNS of_IN subtype_NN C_NP fell_VBD into_IN two_CD different_JJ patterns_NNS defined_VBN by_IN the_DT size_NN of_IN the_DT P1_NP '_POS amino_NN acid_NN :_: type_NN I_PP ,_, represented_VBN by_IN p2/NC_NN and_CC p1/p6gag_NN ,_, and_CC type_NN II_NP ,_, represented_VBN by_IN p17/p24_NN and_CC p24/p2_NN ._SENT Both_DT types_NNS carried_VBD large_JJ nonpolar_NN ,_, hydrophobic_JJ amino_NN acids_NNS (_( leucine_NN ,_, tyrosine_NN ,_, phenylalanine_NN ,_, and_CC methionine_NN )_) at_IN position_NN P1_JJ and_CC either_RB a_DT large_JJ (_( type_NN I_CD )_) or_CC small_JJ (_( type_NN II_CD )_) hydrophobic_JJ amino_NN acid_NN (_( proline_NN ,_, alanine_NN ,_, or_CC glycine_NN )_) at_IN P1_NP '_POS ._SENT MRCAs_NNS and_CC subtype-specific_JJ signature_NN patterns_NNS ._SENT |_SYM A_DT summary_NN of_IN amino_NN acid_NN signature_NN patterns_NNS relative_JJ to_TO the_DT subtype_NN B_NP and_CC C_NP and_CC group_NN M_NP MRCAs_NP is_VBZ shown_VBN in_IN Tables_NP and_NP ._SENT Mutations_NNS at_IN cleavage_NN sites_NNS defining_VBG the_DT enzymatic_JJ (_( PR/RT_NP ,_, RT/p66_NP ,_, and_CC p66/IN_NN )_) and_CC structural_JJ (_( p17/24_JJ ,_, p24/p2_JJ ,_, and_CC NC/p1_JJ )_) components_NNS of_IN HIV-1_NP were_VBD relatively_RB uncommon_JJ and_CC ,_, when_WRB detected_VBN ,_, were_VBD found_VBN at_IN greater_JJR frequencies_NNS among_IN C_NP versus_CC B_NP viruses_NNS ._SENT In_IN total_NN ,_, only_RB 1.2_CD ,_, 0.8_CD ,_, and_CC 1.1_CD %_NN of_IN the_DT 840_CD amino_NN acids_NNS at_IN each_DT of_IN the_DT PR/RT_NP ,_, p66/IN_NN ,_, and_CC p24/p2_JJ cleavage_NN sites_NNS carried_VBD substitutions_NNS ._SENT As_IN a_DT result_NN ,_, the_DT majority_NN of_IN sequences_NNS at_IN conserved_VBN sites_NNS (_( 81.5_CD to_TO 96.7_CD %_NN )_) were_VBD identical_JJ to_TO both_CC the_DT subtype-specific_JJ MRCA_NP and_CC the_DT common_JJ ancestor_NN of_IN the_DT group_NN M_NN viruses_NNS ._SENT Several_JJ cleavage_NN sites_NNS involved_VBN in_IN the_DT regulation_NN of_IN polyprotein_NN processing_NN and_CC protease_NN activation_NN ,_, p2/NC_NP ,_, TFP/p6pol_NP ,_, and_CC p6pol/PR_NN ,_, were_VBD highly_RB variable_JJ and_CC differed_VBD significantly_RB from_IN both_CC the_DT subtype-specific_NN and_CC group_NN M_NP MRCAs_NP ._SENT With_IN the_DT exception_NN of_IN the_DT TFP/p6pol_NP site_NN ,_, which_WDT was_VBD more_RBR variable_JJ in_IN subtype_NN B_NP ,_, divergence_NN from_IN the_DT MRCA_NP was_VBD greatest_JJ for_IN C_NP and_CC M_NP viruses_NNS ._SENT None_NN of_IN the_DT p2/NC_NN and_CC p6pol/PR_NN sequences_NNS in_IN the_DT group_NN M_NN data_NNS set_VBN was_VBD identical_JJ to_TO the_DT M_NP MRCA_NP signatures_NNS for_IN p2/NC_NN and_CC p6pol/PR_NN ,_, STAIM/MQKGN_NP and_CC TSFSF/PQITC_NP ,_, respectively_RB ._SENT Positive_JJ selection_NN of_IN amino_NN acids_NNS at_IN protease_NN cleavage_NN sites_NNS ._SENT |_SYM The_DT concatenated_VBN 360-bp_JJ cleavage_NN site_NN fragments_NNS were_VBD next_RB compared_VBN internally_RB to_TO assess_VB the_DT mutational_JJ behavior_NN of_IN P1-P5_NP and_CC P1'-P5_NP '_POS sites_NNS in_IN the_DT absence_NN of_IN drug_NN therapy_NN ._SENT As_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ,_, the_DT analyses_NNS were_VBD performed_VBN using_VBG codon-based_JJ maximum-likelihood_JJ methods_NNS that_WDT test_VBP for_IN the_DT variation_NN in_IN selection_NN pressure_NN (_( dn/ds_NNS )_) at_IN individual_JJ amino_NN acids_NNS along_IN the_DT length_NN of_IN the_DT sequence_NN ._SENT Application_NN of_IN the_DT likelihood_NN ratio_NN test_NN indicated_VBD that_IN the_DT best-fit_JJ model_NN for_IN subtype_NN C_NN and_CC group_NN M_NN sequences_NNS was_VBD the_DT positive-selection_NN (_( discrete_JJ )_) model_NN (_( chi2_NN =_SYM 54.47_CD ;_: P_NN <_SYM 0.0001_CD and_CC 62.34_CD and_CC P_NN <_0.0001, 0.05_CD )_) ._SENT Overall_RB ,_, when_WRB analyzed_VBN as_IN a_DT single_JJ concatenated_VBN fragment_NN ,_, all_DT three_CD datasets_NNS were_VBD found_VBN to_TO be_VB under_IN negative_JJ (_( purifying_VBG )_) selection_NN ,_, with_IN dn/ds_NNS (_( omega_NN )_) values_NNS ranging_VBG from_IN 0.26_CD to_TO 0.31_CD for_IN all_DT sites_NNS ._SENT Only_RB 20_CD (_( 16.6_CD %_NN )_) of_IN the_DT 120_CD amino_NN acids_NNS within_IN the_DT 12_CD cleavage_NN sites_NNS of_IN subtype_NN C_NP were_VBD found_VBN to_TO be_VB under_IN positive_JJ selection_NN ,_, with_IN a_DT omega3_JJ value_NN of_IN 1.7_CD ._SENT Group_NP M_NP and_CC subtype_NN B_NN cleavage_NN sites_NNS had_VBD fewer_JJR positively_RB selected_VBN amino_NN acids_NNS :_: 11.1_CD and_CC 6.7_CD %_NN ,_, respectively_RB ._SENT The_DT presence_NN of_IN polymorphisms_NNS in_IN the_DT protease_NN of_IN subtype_NN C_NP would_MD be_VB expected_VBN to_TO result_VB in_IN adaptive_JJ (_( compensatory_JJ )_) changes_NNS in_IN the_DT natural_JJ cleavage_NN sites_NNS that_WDT are_VBP recognized_VBN and_CC cleaved_VBN by_IN the_DT C_NP enzyme_NN ._SENT To_TO test_VB this_DT hypothesis_NN ,_, we_PP examined_VBD the_DT prevalences_NNS and_CC patterns_NNS of_IN cleavage_NN site_NN mutations_NNS in_IN the_DT Gag_NP ,_, Gag-Pol_NP ,_, and_CC Nef_NP proteins_NNS of_IN subtype_NN C_NP compared_VBN to_TO those_DT of_IN non-C_NN viruses_NNS ._SENT Using_VBG phylogenetic_JJ and_CC ancestral_JJ reconstruction_NN methods_NNS ,_, we_PP identified_VBD two_CD groups_NNS of_IN natural_JJ cleavage_NN site_NN sequences_NNS ._SENT The_DT first_JJ group_NN consisted_VBN of_IN eight_CD sequences_NNS ,_, seven_CD of_IN which_WDT were_VBD highly_RB conserved_VBN in_IN all_DT HIV-1_JJ subtypes_NNS ,_, and_CC an_DT eighth_JJ sequence_NN which_WDT was_VBD moderately_RB variable_JJ ._SENT Mutations_NNS at_IN these_DT sites_NNS were_VBD uncommon_JJ and_CC ,_, when_WRB present_JJ ,_, were_VBD observed_VBN at_IN relatively_RB equivalent_JJ frequencies_NNS among_IN different_JJ subtypes_NNS ._SENT These_DT cleavage_NN sites_NNS ,_, which_WDT defined_VBD the_DT main_JJ structural_JJ (_( MA_NP ,_, CA_NP ,_, and_CC NC_NP )_) and_CC enzymatic_JJ (_( RT_NP ,_, RNase_NP H_NP ,_, and_CC integrase_NN )_) proteins_NNS of_IN HIV-1_NP ,_, were_VBD under_IN strong_JJ negative_JJ (_( purifying_VBG )_) selection_NN pressure_NN ,_, had_VBD a_DT common_JJ ancestor_NN ,_, and_CC showed_VBD little_JJ genetic_JJ evolution_NN over_IN time_NN ._SENT The_DT second_JJ group_NN consisted_VBN of_IN five_CD cleavage_NN sites_NNS that_WDT were_VBD under_IN positive_JJ (_( diversifying_VBG )_) selection_NN pressure_NN ,_, exhibited_VBN extensive_JJ inter-_NN and_CC intrasubtype_NN variability_NN ,_, and_CC showed_VBD little_RB (_( or_CC no_RB )_) resemblance_NN to_TO the_DT common_JJ ancestor_NN of_IN group_NN M_NN or_CC to_TO the_DT subtype-specific_JJ MRCA_NP ._SENT Our_PP$ data_NNS showing_VBG that_IN the_DT majority_NN (_( 58.3_CD %_NN )_) of_IN cleavage_NN sites_NNS are_VBP highly_RB conserved_VBN in_IN all_DT subtypes_NNS were_VBD not_RB unexpected_JJ ,_, given_VBN the_DT narrow_JJ specificity_NN of_IN the_DT HIV-1_JJ protease_NN relative_JJ to_TO cellular_JJ proteases_NNS ,_, such_JJ as_IN pepsin_NN ._SENT The_DT strong_JJ purifying_VBG selection_NN pressure_NN exerted_VBN on_IN these_DT sites_NNS is_VBZ presumably_RB a_DT reflection_NN of_IN the_DT need_NN to_TO maintain_VB the_DT spatial_JJ configuration_NN of_IN the_DT enzyme-substrate_JJ complex_NN ,_, conserve_VB the_DT hydrophobic_JJ nature_NN of_IN the_DT scissile_JJ bond_NN ,_, and_CC retain_VB the_DT biological_JJ activity_NN of_IN functionally_RB important_JJ sites_NNS ,_, such_JJ as_IN the_DT P1_NP '_POS proline_NN of_IN p17/p24_NN and_CC the_DT P1_NP and_CC P1'-P5_NP '_POS residues_NNS of_IN NC/p1_NP ._SENT Cleavage_NN of_IN the_DT P17/p24_NP site_NN is_VBZ known_VBN to_TO play_VB an_DT important_JJ role_NN in_IN virion_NN maturation_NN ,_, while_IN processing_NN of_IN NC/p1_NP is_VBZ required_VBN for_IN ribosomal_JJ frame_NN shifting_VBG and_CC Gag-Pol_NP expression_NN (_( ,_, -_: ,_, )_) ._SENT In_IN B_NP viruses_NNS ,_, cleavage_NN of_IN p17/24_NN ,_, p24/p2_NN ,_, and_CC NC/p1_NP has_VBZ been_VBN shown_VBN to_TO be_VB suboptimal_JJ ,_, with_IN the_DT NC/p1_JJ site_NN being_VBG rate_NN limiting_VBG ._SENT It_PP has_VBZ been_VBN suggested_VBN that_IN the_DT slow_JJ ,_, regulated_JJ cleavage_NN of_IN these_DT structural_JJ proteins_NNS may_MD represent_VB a_DT common_JJ strategy_NN to_TO ensure_VB that_IN the_DT assembled_VBN virions_NNS have_VBP the_DT full_JJ complement_NN of_IN proteins_NNS needed_VBN to_TO bud_VB from_IN the_DT cell_NN surface_NN ,_, bind_NN to_TO a_DT new_JJ cell_NN ,_, and_CC initiate_VB a_DT new_JJ round_NN of_IN viral_JJ replication_NN ._SENT The_DT carboxyl_NN terminus_NN of_IN NC_NP is_VBZ particularly_RB interesting_JJ ._SENT Unlike_IN other_JJ cleavage_NN sites_NNS ,_, which_WDT carry_VBP an_DT aromatic_JJ amino_NN acid_NN at_IN P1_JJ and_CC either_RB a_DT leucine_NN or_CC proline_NN residue_NN at_IN P1_NP '_POS ,_, the_DT C_NP termini_NNS of_IN NC/p1_NP and_CC NC/TFP_NP carry_VBP an_DT asparagine_NN (_( N_NP )_) residue_NN at_IN P1_NP opposite_IN a_DT phenylalanine_NN (_( F_NN )_) residue_NN at_IN P1_NP '_'' (_( ,_, -_: )_) ._SENT In_IN this_DT study_NN of_IN 84_CD untreated_JJ patients_NNS ,_, no_DT mutations_NNS were_VBD detected_VBN at_IN the_DT P2_NP or_CC P1'-P3_NP '_POS positions_NNS of_IN NC/p1_NP or_CC NC/TFP_NP and_CC only_RB a_DT single_JJ N->C_NP mutation_NN was_VBD detected_VBN at_IN P1_NP ._SENT Taken_VBN together_RB ,_, these_DT findings_NNS underscore_VBP the_DT unique_JJ nature_NN and_CC limited_JJ mutability_NN of_IN the_DT NC/p1_NP and_CC NC/TFP_NP cleavage_NN junctions_NNS ._SENT Although_IN these_DT sites_NNS were_VBD strongly_RB conserved_VBN in_IN natural_JJ infection_NN ,_, recent_JJ studies_NNS have_VBP shown_VBN that_IN an_DT A->V_NP substitution_NN at_IN the_DT P2_JJ positions_NNS of_IN NC/p1_NP and_CC NC/TFP_NP is_VBZ a_DT common_JJ adaptive_JJ change_NN ,_, occurring_VBG in_IN 29_CD %_NN of_IN PI-resistant_JJ patients_NNS taking_VBG indinavir_NN ,_, saquinavir_NN ,_, and/or_CC ritonavir_NN for_IN the_DT treatment_NN of_IN subtype_NN B_NN ._SENT This_DT valine_NN substitution_NN is_VBZ frequently_RB associated_VBN with_IN an_DT M46_NP I_NP or_CC L_NP mutation_NN (_( and_CC possibly_RB a_DT V82_NP mutation_NN )_) in_IN the_DT protease_NN and_CC leads_VBZ to_TO altered_VBN polyprocessing_NN and_CC improved_VBN growth_NN of_IN protease-mutated_JJ viruses_NNS ._SENT Whether_IN similar_JJ "_`` second-locus_NN "_'' mutations_NNS will_MD be_VB observed_VBN during_IN the_DT treatment_NN of_IN non-B_NN subtypes_NNS remains_VBZ to_TO be_VB established_VBN ._SENT The_DT identification_NN of_IN common_JJ patterns_NNS may_MD facilitate_VB the_DT development_NN of_IN broad-based_JJ inhibitors_NNS with_IN increased_VBN specificity_NN and_CC improved_VBD binding_VBG to_TO the_DT mutated_VBN protease_NN ._SENT These_DT secondary_JJ inhibitors_NNS might_MD preempt_VB (_( or_CC delay_VB )_) the_DT emergence_NN of_IN resistance_NN ._SENT Our_PP$ analyses_NNS also_RB revealed_VBD important_JJ differences_NNS among_IN HIV-1_JJ subtypes_NNS ._SENT Particularly_RB intriguing_JJ was_VBD the_DT identification_NN of_IN five_CD cleavage_NN sites_NNS that_WDT exhibited_VBD extensive_JJ variability_NN across_IN all_DT subtypes_NNS ,_, with_IN C_NP viruses_NNS being_VBG significantly_RB more_JJR variable_NN than_IN subtype_NN B._NP Variation_NP was_VBD restricted_VBN to_TO a_DT few_JJ specific_JJ amino_NN acids_NNS ,_, most_JJS of_IN which_WDT were_VBD positively_RB selected_VBN in_IN C_NP but_CC not_RB in_IN B_NP viruses_NNS ._SENT In_IN contrast_NN to_TO conserved_VBN sites_NNS ,_, variable_JJ cleavage_NN sites_NNS tended_VBD to_TO be_VB those_DT with_IN regulatory_JJ rather_RB than_IN structural_JJ or_CC enzymatic_JJ functions_NNS ._SENT At_IN least_JJS four_CD of_IN the_DT variable_JJ sites_NNS (_( p2/NC_NP ,_, p1/p6gag_NP ,_, TFP/p6pol_NP ,_, and_CC p6pol/PR_NN )_) are_VBP known_VBN to_TO play_VB major_JJ roles_NNS in_IN the_DT regulation_NN of_IN polyprotein_NN processing_NN and_CC ,_, in_IN the_DT case_NN of_IN TFP/p6pol_NP ,_, in_IN the_DT activation_NN of_IN the_DT protease_NN enzyme_NN (_( -_: ,_, ,_, )_) ._SENT Studies_NNS of_IN subtype_NN B_NN have_VBP shown_VBN that_IN p2/NC_NN is_VBZ the_DT initial_JJ and_CC most_RBS rapidly_RB processed_VBN cleavage_NN site_NN ,_, controlling_VBG both_CC the_DT rate_NN and_CC the_DT order_NN of_IN Gag_NP and_CC Gag-Pol_NP polyprocessing_NN ._SENT Our_PP$ results_NNS indicate_VBP that_IN p2/NC_NN is_VBZ by_IN far_RB the_DT most_RBS variable_JJ cleavage_NN site_NN ,_, with_IN intrasubtype_NN diversity_NN ranging_VBG from_IN 18.7_CD %_NN in_IN subtype_NN B_NN to_TO levels_NNS of_IN 42.4_CD %_NN in_IN subtype_NN C._NP The_DT p1/p6gag_NN cleavage_NN product_NN ,_, p6gag_NN ,_, is_VBZ a_DT major_JJ phosphoprotein_NN that_WDT is_VBZ critical_JJ to_TO the_DT release_NN of_IN mature_JJ ,_, infectious_JJ virions_NNS ._SENT Although_IN not_RB well_RB studied_VBN ,_, phosphorylation_NN of_IN Gag_NP and_CC Gag-Pol_NP sequences_NNS has_VBZ been_VBN shown_VBN to_TO alter_VB susceptibility_NN to_TO cleavage_NN ,_, attenuating_VBG or_CC even_RB preventing_VBG the_DT proteolytic_JJ process_NN ._SENT The_DT TFP/p6pol_NP cleavage_NN site_NN ,_, defining_VBG the_DT N_NP terminus_NN of_IN p6pol_NP ,_, was_VBD the_DT only_JJ site_NN to_TO have_VB a_DT significantly_RB higher_JJR level_NN of_IN diversity_NN among_IN B_NP than_IN among_IN C_NP viruses_NNS ._SENT TFP/p6pol_NP is_VBZ a_DT novel_JJ cleavage_NN site_NN located_VBN 8_CD amino_NN acids_NNS downstream_JJ from_IN NC_NP in_IN the_DT TFP_NN domain_NN of_IN Gag-Pol_NP ._SENT Although_IN TFP/p6pol_NP lies_VBZ outside_IN (_( and_CC upstream_RB )_) of_IN the_DT protease_NN ,_, the_DT EDL_NP tripeptide_NN of_IN this_DT cleavage_NN site_NN (_( ENL_NP in_IN the_DT case_NN of_IN C_NP viruses_NNS )_) has_VBZ been_VBN postulated_VBN to_TO have_VB a_DT major_JJ influence_NN on_IN protease_NN activation_NN and_CC on_IN the_DT timing_NN and_CC specificity_NN of_IN Gag-Pol_NP cleavage_NN ,_, delaying_VBG the_DT release_NN of_IN the_DT protease_NN until_IN after_IN the_DT viral_JJ particle_NN has_VBZ budded_VBN from_IN the_DT cell_NN membrane_NN ._SENT Such_PDT a_DT mechanism_NN may_MD protect_VB the_DT cell_NN from_IN the_DT cytotoxic_JJ effects_NNS of_IN proteolysis_NN ._SENT The_DT observed_JJ subtype_NN variation_NN in_IN the_DT cleavage_NN sites_NNS controlling_VBG the_DT initiation_NN and_CC rate_NN of_IN Gag_NP and_CC Gag-Pol_NP processing_NN (_( p2/NC_NN )_) and_CC the_DT activation_NN of_IN protease_NN (_( TFP/p6gag_NP )_) suggests_VBZ that_IN there_EX may_MD be_VB important_JJ differences_NNS in_IN the_DT way_NN that_IN B_NP and_CC C_NP viruses_NNS regulate_VB polyprocessing_NN and_CC virion_NN assembly_NN ._SENT Subtle_JJ cleavage_NN site_NN differences_NNS could_MD ,_, over_IN time_NN ,_, have_VBP a_DT major_JJ differential_JJ impact_NN on_IN the_DT pathogenesis_NN of_IN HIV-1_JJ subtypes_NNS and_CC on_IN response_NN to_TO therapy_NN ._SENT Early_JJ treatment_NN studies_NNS suggest_VBP that_IN C_NP viruses_NNS give_VBP an_DT excellent_JJ initial_JJ response_NN to_TO highly_RB active_JJ antiretroviral_JJ therapy_NN but_CC that_IN the_DT duration_NN of_IN the_DT response_NN may_MD be_VB less_JJR than_IN that_DT reported_VBN for_IN B_NP viruses_NNS ._SENT In_IN summary_NN ,_, our_PP$ results_NNS point_VBP to_TO important_JJ inter-_NN and_CC intrasubtype_NN differences_NNS in_IN protease_NN cleavage_NN sites_NNS ,_, especially_RB in_IN the_DT p2/NC_NN ,_, TFP/p6pol_NP ,_, and_CC p6pol/PR_NN sites_NNS ._SENT The_DT main_JJ limitations_NNS of_IN our_PP$ study_NN relate_VBP to_TO the_DT cross-sectional_JJ nature_NN of_IN the_DT data_NN sets_NNS and_CC the_DT limited_JJ availability_NN of_IN well-matched_JJ pretreatment_NN controls_NNS for_IN use_NN in_IN the_DT B_NP data_NNS set_VBD ._SENT Despite_IN these_DT limitations_NNS ,_, the_DT potential_JJ impact_NN of_IN our_PP$ findings_NNS on_IN HIV-1_JJ disease_NN progression_NN and_CC response_NN to_TO therapy_NN warrants_NNS further_JJR investigation_NN ,_, both_CC at_IN the_DT patient_JJ level_NN and_CC in_IN vitro_NN using_VBG site-directed_JJ mutagenesis_NN ._SENT The_DT separate_JJ monophyletic_JJ clustering_VBG of_IN B_NP and_CC C_NP cleavage_NN sites_NNS suggests_VBZ that_IN cleavage_NN sites_NNS have_VBP evolved_VBN in_IN a_DT subtype-specific_JJ manner_NN ._SENT The_DT divergence_NN between_IN ancestral_JJ and_CC contemporary_JJ sequences_NNS in_IN the_DT C_NP data_NNS set_VBD and_CC the_DT location_NN of_IN an_DT ancestral_JJ node_NN distal_JJ to_TO the_DT group_NN M_NP MRCA_NP suggest_VBP that_DT variation_NN in_IN C_NP cleavage_NN sites_NNS began_VBD early_JJ ,_, prior_JJ to_TO the_DT diversification_NN of_IN HIV-1_JJ subtypes_NNS ._SENT A_DT more_RBR detailed_JJ investigation_NN of_IN C_NP cleavage_NN sites_NNS ,_, both_CC over_IN time_NN and_CC in_IN response_NN to_TO therapy_NN ,_, is_VBZ in_IN progress_NN ._SENT The_DT present_JJ study_NN forms_VBZ the_DT baseline_NN for_IN these_DT ongoing_JJ studies_NNS ._SENT Schematic_JJ of_IN the_DT Gag_NP and_CC Gag-Pol_NP processing_NN sites_NNS showing_VBG the_DT 12_CD individual_JJ protease_NN cleavage_NN sites_NNS :_: 5_CD cleavage_NN sites_NNS in_IN Gag_NP (_( p17/p24_NP ,_, p24/p2_NN ,_, p2/NC_NN ,_, p7/p1_JJ ,_, and_CC p1/p6gag_NN )_) ,_, 6_CD cleavage_NN sites_NNS in_IN Gag-Pol_NP (_( NC/TFP_NP ,_, TFP/p6pol_NP ,_, p6pol/PR_NP ,_, PR/RT_NP ,_, RT/p66_NP ,_, and_CC p66/IN_NN )_) ,_, and_CC a_DT single_JJ site_NN in_IN Nef_NP ._SENT Schematic_JJ of_IN the_DT Gag_NP and_CC Gag-Pol_NP processing_NN sites_NNS showing_VBG the_DT 12_CD individual_JJ protease_NN cleavage_NN sites_NNS :_: 5_CD cleavage_NN sites_NNS in_IN Gag_NP (_( p17/p24_NP ,_, p24/p2_NN ,_, p2/NC_NN ,_, p7/p1_JJ ,_, and_CC p1/p6gag_NN )_) ,_, 6_CD cleavage_NN sites_NNS in_IN Gag-Pol_NP (_( NC/TFP_NP ,_, TFP/p6pol_NP ,_, p6pol/PR_NP ,_, PR/RT_NP ,_, RT/p66_NP ,_, and_CC p66/IN_NN )_) ,_, and_CC a_DT single_JJ site_NN in_IN Nef_NP ._SENT The_DT frequency_NN of_IN amino_NN acid_NN substitution_NN at_IN each_DT of_IN these_DT cleavage_NN sites_NNS is_VBZ shown_VBN in_IN Fig._NN and_CC Tables_NP and_NP ._SENT Amino_NN acid_NN polymorphisms_NNS at_IN Gag_NP ,_, Gag-Pol_NP ,_, and_CC Nef_NP cleavage_NN sites_NNS ._SENT Amino_NN acid_NN polymorphisms_NNS at_IN Gag_NP ,_, Gag-Pol_NP ,_, and_CC Nef_NP cleavage_NN sites_NNS ._SENT The_DT letters_NNS refer_VBP to_TO the_DT amino_NN acid_NN substitutions_NNS ;_: the_DT numbers_NNS in_IN parentheses_NNS refer_VBP to_TO the_DT number_NN of_IN times_NNS the_DT substitution_NN was_VBD observed_VBN ._SENT Each_DT cleavage_NN site_NN sequence_NN consists_VBZ of_IN the_DT 5_CD amino_NN acids_NNS upstream_RB and_CC the_DT 5_CD amino_NN acids_NNS downstream_JJ of_IN the_DT scissile_JJ bond_NN ,_, indicated_VBN by_IN a_DT shill_NN ._SENT The_DT labeling_VBG of_IN amino_NN acids_NNS is_VBZ according_VBG to_TO the_DT convention_NN of_IN P1_NP to_TO P5_NP going_VBG from_IN the_DT scissile_JJ bond_NN toward_IN the_DT amino_NN terminus_NN and_CC P1_JJ '_'' to_TO P5_NP '_POS going_VBG toward_IN the_DT carboxy_JJ terminus_NN ._SENT Positively_RB selected_VBN amino_NN acids_NNS are_VBP marked_VBN with_IN asterisks_NNS ._SENT Dots_NNS represent_VBP amino_NN acids_NNS that_WDT are_VBP identical_JJ to_TO those_DT in_IN the_DT M_NP MRCA_NP ._SENT Phylogenetic_JJ relationships_NNS of_IN the_DT South_NP African_NP Tygerberg_NP virology_NN (_( TV_NN )_) cleavage_NN site_NN sequences_NNS relative_JJ to_TO other_JJ subtypes_NNS in_IN the_DT group_NN M_NN data_NNS set_VBD ._SENT Phylogenetic_JJ relationships_NNS of_IN the_DT South_NP African_NP Tygerberg_NP virology_NN (_( TV_NN )_) cleavage_NN site_NN sequences_NNS relative_JJ to_TO other_JJ subtypes_NNS in_IN the_DT group_NN M_NN data_NNS set_VBD ._SENT This_DT representative_JJ maximum-likelihood_JJ tree_NN is_VBZ based_VBN on_IN concatenation_NN and_CC analysis_NN of_IN the_DT 12_CD protease_NN site_NN nucleotide_NN sequences_NNS as_IN a_DT single_JJ segment_NN of_IN 360_CD bp_NN ._SENT An_DT indication_NN of_IN the_DT degree_NN of_IN sequence_NN dissimilarity_NN is_VBZ given_VBN by_IN the_DT distance_NN from_IN the_DT central_JJ node_NN ._SENT The_DT percentage_NN of_IN bootstrap_NN trees_NNS out_RB of_IN 1,000_CD replications_NNS supporting_VBG a_DT particular_JJ phylogenetic_JJ group_NN is_VBZ shown_VBN alongside_IN the_DT node_NN considered_VBD ._SENT Sequences_NNS used_VBN for_IN the_DT analysis_NN of_IN protease_NN cleavage_NN sitesa_NN Inter-_NP and_CC intrasubtype_JJ diversity_NN at_IN 12_CD cleavage_NN sites_NNS ,_, expressed_VBN as_IN amino_NN acid_NN distances_NNS between_IN sequences_NNS Relationship_NN between_IN cleavage_NN site_NN signature_NN patterns_NNS and_CC common_JJ ancestors_NNS Relationship_NN between_IN cleavage_NN site_NN signature_NN patterns_NNS and_CC common_JJ ancestors_NNS 